Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic CancerEric Van Cutsem, Malcolm J. Moore, Walter L. Vervenne et al.|Journal of Clinical Oncology|2009Cited by 643
An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancerThomas Powles, Dónal Landers, Florence Joly et al.|Nature Medicine|2021Cited by 115